Göbel, A., Zinna, V. M., Dell’Endice, S., Jaschke, N., Kuhlmann, J. D., Wimberger, P., & Rachner, T. D. (2020). Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer. BMC Cancer.
Παραπομπή Chicago StyleGöbel, Andy, Valentina M. Zinna, Stefania Dell’Endice, Nikolai Jaschke, Jan Dominik Kuhlmann, Pauline Wimberger, και Tilman D. Rachner. "Anti-tumor Effects of Mevalonate Pathway Inhibition in Ovarian Cancer." BMC Cancer 2020.
Παραπομπή MLAGöbel, Andy, et al. "Anti-tumor Effects of Mevalonate Pathway Inhibition in Ovarian Cancer." BMC Cancer 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.